B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ceftizoxime

299 PubMed studies analyzed ยท 44 RCTs ยท Evidence Score: 48.9

Research Domains

Ceftizoxime has been studied across 12 research domains including ๐Ÿซ˜ Kidney, ๐Ÿ˜ด Sleep, ๐Ÿง  Focus & Attention, ๐Ÿซ Respiratory, ๐Ÿ›ก๏ธ Immunity. The primary research focus is ๐Ÿซ˜ Kidney with 6% of studies addressing this area.

Loading evidence profile...

This evidence profile for Ceftizoxime is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.